Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06932588 · ClinicalTrials.gov registry record · NA
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
A NA study of Brain Injuries and Head Injury, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06932588: Recruiting NA study of Brain Injuries and Head Injury, sponsored by Emory University.
NCT06932588 is a NA study of Brain Injuries and Head Injury that is actively recruiting participants, run by Emory University. The registered enrollment target is 350 participants, above the 315-participant average among 22 other Brain Injuries trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06932588, a NA study of Brain Injuries and Head Injury, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine whether a blood test can help doctors decide when to use a head CT scan for patients with a mild head injury. Researchers are investigating whether the results from this blood test can aid in making better decisions about patient care and potentially reduce the need for imaging. In this study, researchers will collect blood samples to assess whether this specific blood test can help doctors decide when head imaging is necessary following a head injury. The goal is to determine whether the use of this test can reduce the number of head imaging procedures performed in the emergency department (ED).
Primary Outcome
The impact of biomarker results will be measured by the decision to obtain CT head imaging for patients presenting with mild TBI.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT
Study Locations (1)
Georgia
- Grady Health System - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-05-31 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06932588 shows while recruiting
NCT06932588 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 315-participant average among 22 other Brain Injuries trials with a reported enrollment target (11% higher).
The record links to 2 conditions, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT is the first listed.
NCT06932588 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06932588 about?
NCT06932588 is a clinical study titled "Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma". This study aims to determine whether a blood test can help doctors decide when to use a head CT scan for patients with a mild head injury. Researchers are investigating whether the results from this blood test can aid in making better decisions about patient care and potentially reduce the need for ...
What is the current status of trial NCT06932588?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2025-05-31. Estimated completion is 2026-06.
What conditions does trial NCT06932588 study?
This clinical trial studies the following conditions: Brain Injuries, Head Injury.
What interventions are being tested in trial NCT06932588?
The interventions under investigation include: Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06932588?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06932588 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06932588's enrollment target sits among peer trials
350 5th of 22 higher than 18 of 22 other Brain Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
RECRUITING · NA
-
Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.
RECRUITING · NA
-
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI